With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming ...

Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...

Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

Medicine company Novartis (NVS) said on Thursday that a late-stage trial evaluating its drug Cosentyx in adults with newly diagnosed or relapsing giant cell arteritis failed to meet its primary goal ...

Response and remission rates failed to beat placebo in a new Harvard meta-analysis, throwing the inflammation hypothesis into ...

Ultragenyx Pharmaceutical said on Monday that its ‍experimental drug for a type of genetic bone disease did not meet the main goal ‌in late-stage ‌studies. The company was testing the treatment called ...

TRENTON, N.J. (AP) -- A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the ...

Before Patchy Mix’s arrival in the UFC, the former Bellator bantamweight champion showcased high-level grappling and finishing prowess, capturing the title and winning the $1 million Bantamweight ...

Seattle and San Francisco scale back harm reduction policies distributing drug supplies, signaling a shift in how West Coast ...